Granite Bay Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $401K | Buy |
900
+300
| +50% | +$134K | 0.13% | 45 |
|
|
2025
Q1 | $291K | Sell |
600
-304
| -34% | -$147K | 0.1% | 59 |
|
|
2024
Q4 | $364K | Buy |
904
+4
| +0.4% | +$1.61K | 0.13% | 53 |
|
|
2024
Q3 | $419K | Hold |
900
| – | – | 0.24% | 31 |
|
|
2024
Q2 | $422K | Hold |
900
| – | – | 0.23% | 42 |
|
|
2024
Q1 | $376K | Sell |
900
-60,525
| -99% | -$25.3M | 0.21% | 56 |
|
|
2023
Q4 | $22.7M | Buy |
61,425
+21,450
| +54% | +$7.92M | 0.2% | 51 |
|
|
2023
Q3 | $14M | Buy |
39,975
+39,375
| +6,563% | +$13.8M | 0.14% | 70 |
|
|
2023
Q2 | $211K | Buy |
+600
| New | +$211K | 0.2% | 42 |
|
|
2022
Q2 | – | Sell |
-810
| Closed | -$211K | – | 62 |
|
|
2022
Q1 | $211K | Sell |
810
-190
| -19% | -$49.5K | 0.17% | 58 |
|
|
2021
Q4 | $220K | Buy |
+1,000
| New | +$220K | 0.22% | 57 |
|